Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT07138313
Recruiting Not applicable

Dietary Impact on Sleep, Rhythms and Related Physiology

NCT07138313 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2025-09-22
Last updated
2026-02-04

Condition(s) studied

SleepDiet InterventionsCircadian Rhythm

Investigational drug(s) / intervention(s)

Low-fat dietary interventionHigh-fat dietary intervention

Low-fat dietary intervention: Low-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).

High-fat dietary intervention: High-fat diet for approximately 1 week, preceding in-lab study period (approximately 2 days) under standardized conditions (total dietary exposure up to 9-10 days).

Study summary

Sleep and metabolism are closely interconnected, and emerging evidence suggests that dietary composition may influence both sleep quality and key physiological functions such as glucose regulation, cardiovascular activity, and hormonal signaling. This study aims to investigate how a Western-style unhealthy diet versus a healthier, fiber-rich diet affects objective and subjective sleep measures, 24-hour physiological parameters, and a range of biomarkers related to cardiometabolic, neurodegenerative, and gut microbial function.

Eligibility

Sex
ALL
Min age
18 Years
Max age
32 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18-32 yr * Healthy (self-reported) and not on chronic medication * BMI 18-27 kg/m2 (and waist circumference \<102 cm), and weight stable (less than 5% body weight change in the past 6 months) * Non-smoker and non-nicotine user * Regular sleep-wake pattern, with sleep duration of 7-9.25 hrs per night * Regular exercise habits the last 2 months * Regular daily meal pattern with 3 main meals Exclusion Criteria: * Major or chronic illness, e.g. diabetes, renal disease or inflammatory bowel disease * Current or history of endocrine or metabolic disorders * Psychiatric or neurological disorders (e.g. bipolar disorder, epilepsy) * Frequent gastrointestinal symptoms * Chronic medication * Any sleep disorder (including recent or chronic symptoms of insomnia) * Shift work in the preceding three months or for a long duration * Extreme chronotype or physical activity patterns * Time travel over two time zones in the preceding month * Too much weight gain or weight loss in the preceding 6 months (±5% body weight in past 6 months) * Any issues with or allergies against the provided food items * Recent major dietary changes or adoption of specific dietary regimens * Women who are pregnant, breastfeeding, or planning to become pregnant during the study period. * Use of illicit drugs or substances of abuse

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Uppsala biomedical center Uppsala Sweden Recruiting

More Uppsala University trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07138313 on ClinicalTrials.gov ↗ ← All trials in Sweden